Linomide is primarily investigated for its immunomodulatory properties, making it a candidate for therapeutic applications in autoimmune diseases and cancer. It has been studied for its potential to enhance immune responses, particularly in the context of stimulating natural killer cells and T-cells, which are crucial for combating tumor growth and viral infections. In clinical trials, Linomide has been explored as an adjunct therapy in multiple sclerosis to modulate the immune system and reduce disease progression. Additionally, its anti-angiogenic effects have been examined in cancer research, where it may help inhibit the formation of new blood vessels that supply tumors, thereby limiting their growth. Despite its potential, further research is needed to fully understand its efficacy and safety profile in various medical applications.